跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Blimuca 600 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Blimuca 600
Approved
STANDARD
Blimuca 600
Nabros Pharma Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
fab38a90aa34a6cb
Company
Nabros Pharma Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
fab38a90aa34a6cb
Drug Approval Philippines Name
Blimuca 600
Product Name
Blimuca 600
Registration Number
DRP-16288
Brand Name
Blimuca 600
Generic Name
Acetylcysteine
Dosage Form
Powder for Oral Solution
Dosage Strength
600 mg
Manufacturer
Nabros Pharma Pvt. Ltd.
Importer
Bliss Pharma Distribution and Consultancy Corp.
Distributor
Bliss Pharma Distribution and Consultancy Corp.
Issuance Date
27 January 2025
Expiry Date
27 January 2030
Pharmacologic Category
Mucolytic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
fab38a90aa34a6cb
Type
Standard
Back to Philippines FDA Approvals